Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: Lessons from the GUSTO-IIb Angioplasty Substudy

[1]  M. Hadamitzky,et al.  Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. , 1998, Journal of the American College of Cardiology.

[2]  M. Leon,et al.  The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. , 1998, Journal of the American College of Cardiology.

[3]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .

[4]  C. Bauters,et al.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. , 1997, Circulation.

[5]  R. Califf,et al.  Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction , 1997 .

[6]  M. Simoons,et al.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.

[7]  M. Leon,et al.  Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. , 1997, Circulation.

[8]  J. Chesebro,et al.  Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.

[9]  D. Bell.  Diabetes mellitus and coronary artery disease. , 1996, Journal of cardiovascular risk.

[10]  R. Califf,et al.  Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. , 1996, Journal of the American College of Cardiology.

[11]  D. Faxon,et al.  Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1996, Circulation.

[12]  Nicole E. Jelesoff,et al.  Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials. , 1996, Coronary artery disease.

[13]  F Van de Werf,et al.  Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. , 1996, Journal of the American College of Cardiology.

[14]  M. Simoons.  A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. , 1996, The New England journal of medicine.

[15]  C. White,et al.  Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[16]  F. Balestra,et al.  Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. GISSI--Avoidable Delay Study Group. , 1995, Archives of internal medicine.

[17]  Alan C. Wilson,et al.  Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study , 1995 .

[18]  J. O’Keefe,et al.  Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. , 1995, Journal of the American College of Cardiology.

[19]  W. Weintraub,et al.  Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.

[20]  B. Sobel,et al.  Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. , 1995, Circulation.

[21]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[22]  M. Gammage,et al.  Acute Myocardial Infarction in Diabetic Patients in the Thrombolytic Era , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[23]  J. McGill,et al.  Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients , 1994, Diabetes.

[24]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[25]  J. Yudkin,et al.  Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? , 1993, British heart journal.

[26]  H. White,et al.  Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy , 1993 .

[27]  R. Califf,et al.  Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1993, Journal of the American College of Cardiology.

[28]  D. Vergani,et al.  Clinical correlation between diabetic and non diabetic patients with myocardial infarction. , 1991, Acta cardiologica.

[29]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[30]  D. Singer,et al.  Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors , 1989, Diabetes.

[31]  M. Savage,et al.  Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. , 1988, The American journal of cardiology.

[32]  M. LeFree,et al.  Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. , 1987, Circulation.

[33]  M. Grujic,et al.  [Diabetes mellitus and coronary disease]. , 1971, Medicinski arhiv.